Hence, identification of differentially expressed proteins on the surface of cancer cells expressing oncogenic KRas may provide distinct opportunities for translation of these findings into innovative treatments [7] aimed directly at proteins unique to or exceedingly upregulated on the KRas surface. The gene discussed is KRAS; the disease is cancer.